Clinical studies recruiting near Redlands

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au
Phase 3 · Local Institution - 0083 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404 A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
Phase 3 · Local Institution - 0083 · Bristol-Myers Squibb · NCT07288567 A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Sympt
Phase 4 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT07105111 A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Phase N/A · Retina Consultants of Southern CA · Astellas Pharma Global Development, Inc. · NCT06779773 A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Phase 3 · Anderson Clinical Research · Bristol-Myers Squibb · NCT06976216 Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing
NA · Loma Linda University · University of British Columbia · NCT04634240 Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
Phase 2 · Clinical Site · Intra-Cellular Therapies, Inc. · NCT06480383 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Phase 3 · Clinical Research Site · Axsome Therapeutics, Inc. · NCT07484217 Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Deg
Phase 3 · Adverum Clinical Site 215 · Adverum Biotechnologies, Inc. · NCT07482176 A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary
Phase 3 · California Eye Specialists Medical Group, Inc. · Kodiak Sciences Inc · NCT06990399 Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Phase 3 · Inland Psychiatric Medical Group Inc · Intra-Cellular Therapies, Inc. · NCT06372964 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06627647 Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
Phase 3 · Emad Ibrahim, MD, Inc · Italfarmaco · NCT06093672 A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Phase 4 · Clinical Research Site · Axsome Therapeutics, Inc. · NCT06223880 Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatri
Phase 3 · Inland Psychiatric Medical Group Inc · Intra-Cellular Therapies, Inc. · NCT06690398 Randomised Evaluation of Sodium Dialysate Levels on Vascular Events
Phase 4 · University of Sydney · NCT02823821 A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melan
Phase 3 · Emad Ibrahim, MD, Inc. · Regeneron Pharmaceuticals · NCT06246916 A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resist
Phase 3 · Emad Ibrahim,MD,INC. ( Site 0012) · Merck Sharp & Dohme LLC · NCT06136650 MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Stryker Instruments · NCT03072927 Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Phase 3 · Clinical Research Site · Axsome Therapeutics, Inc. · NCT07398417 Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Neg
Phase 3 · Emad Ibrahim, MD, INC · Gilead Sciences · NCT05633654 COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Phase 3 · California Eye Specialists Medical Group, Inc. · EyePoint Pharmaceuticals, Inc. · NCT07449936 A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Phase 2/Phase 3 · Retina Consultants of Southern California (Site 043) · EyeBiotech Ltd. · NCT07440225 A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Ep
Phase 3 · Inland Psychiatric Medical Group /ID# 274621 · AbbVie · NCT04777357 The Impact of Melatonin Lotion on Sleep and Mental Health
NA · University of Redlands · University of Redlands · NCT06768749 A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult
Phase 3 · California Eye Specialists Medical Group, Inc. · Regeneron Pharmaceuticals · NCT06541704 A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Phase 2 · Anderson Clinical Research ( Site 1024) · Merck Sharp & Dohme LLC · NCT07033494 Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spect
Phase 3 · Inland Psychiatric Medical Group Inc · Intra-Cellular Therapies, Inc. · NCT06229210 CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Phase 3 · Retina Consultants of Southern California · EyePoint Pharmaceuticals, Inc. · NCT07449923

Look up another city

Look up another condition